[1] MUSUMECI G, AIELLO FC, SZYCHLINSKA MA, et al. Osteoarthritis in the XXIst Century: Risk Factors and Behaviours that Influence Disease Onset and Progression. Int J Mol Sci. 2015;16(3):6093-6112.
[2] MUSUMECI G, LORETO C, CARNAZZA ML, et al. Characterization of apoptosis in articular cartilage derived from the knee joints of patients with osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19(2):307-313.
[3] ZHANG J, CHEN S, CHEN W, et al. Ultrastructural change of the subchondral bone increases the severity of cartilage damage in osteoporotic osteoarthritis of the knee in rabbits. Pathol Res Pract. 2018;214(1):38-43.
[4] MENG JH, MA XC, LI ZM, et al. Original article Aquaporin-1 and aquaporin-3 expressions in the temporomandibular joint condylar cartilage after an experimentally induced osteoarthritis. Chin Med J (Engl). 2007;120(24):2191-2194.
[5] 李孝栋,张丽红,肖晓金,等. 透骨消痛胶囊质量标准的研究[J].福建中医药,2012,43(1):57-59.
[6] 林木南,刘献祥.透骨消痛方治疗膝骨性关节炎30例[J].福建中医药,2005,36(4):242-242.
[7] 洪昆达,万甜,李俐,等. 温针合透骨消痛胶囊内服治疗疼痛性膝骨性关节炎30例[J].中医药通报,2010,9(3):55-56.
[8] 吴广文,褚剑锋,许惠凤,等.透骨消痛胶囊含药血清对退变关节软骨细胞表达TNF-α、IL-1β的影响[J].世界中西医结合杂志, 2012,7(4):295-298,310.
[9] LI XH, WU MX, YE HZ, et al. Experimental study on the suppression of sodium nitroprussiate-induced chondrocyte apoptosis by Tougu Xiaotong Capsule (透骨消痛胶囊)-containing serum. Chin J Integr Med. 2011;17(6):436-443.
[10] 黄云梅,陈文列,林如辉,等.透骨消痛胶囊促进成骨细胞的增殖和分化[J].中国组织工程研究,2013,17(33):5923-5928.
[11] WU G, ZHANG J, CHEN W, et al. Tougu Xiaotong capsule exerts a therapeutic effect on knee osteoarthritis by regulating subchondral bone remodeling. Mol Med Rep. 2019;19(3):1858-1866.
[12] ZHANG J, CHEN S, CHEN W,et al. Ultrastructural change of the subchondral bone increases the severity of cartilage damage in osteoporotic osteoarthritis of the knee in rabbits. Pathol Res Pract. 2018;214(1):38-43.
[13] 吴广文,叶锦霞,郑春松,等.骨性关节炎模型大鼠关节软骨变化及透骨消痛胶囊干预的作用[J].中国组织工程研究,2014,18(49): 58-63.
[14] KRENN V, PERINO G , RÜTHER, W, et al. 15 years of the histopathological synovitis score, further development and review: A diagnostic score for , and orthopaedics. Pathol Res Pract. 2017; 213(8):874-881.
[15] KRENN V, MORAWIETZ L, HÄUPL T, et al. Grading of Chronic Synovitis -A Histopathological Grading System for Molecular and Diagnostic Pathology. Pathol Res Pract. 2002;198(5):317-325.
[16] SUTTON S, CLUTTERBUCK A, HARRIS P, et al.The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J. 2009;179(1):10-24.
[17] 杨威,康武林,袁普卫,等.滑膜炎在骨关节炎发病机制中作用的研究进展[J].中国康复理论与实践,2015,21(5):530-533.
[18] BIJLSMA JW, BERENBAUM F, LAFEBER FP. Osteoarthritis: an update with relevance for clinical practice.Lancet. 2011;377(9783):2115-2126.
[19] BONDESON J, BLOM AB, WAINWRIGHT S, et al. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum. 2010;62(3):647-657.
[20] SOKOLOVE J, LEPUS CM. Role of inflammation in the pathogenesis of tosteoarthritis:Latest findings and interpretations. Ther Adv Musculoskelet Dis. 2013;5(2):77-94.
[21] VERKMAN AS, ANDERSON MO, PAPADOPOULOS MC. Aquaporins: important but elusive drug targets. Nat Rev Drug Discov. 2014;13(4): 259-277.
[22] 冯芳芳,于超,谭春江,等.水通道蛋白的表达与关节炎关系的研究进展[J].中国骨与关节杂志,2015,4(4):323-327.
|